OTC DEAL TRENDS 2017
8 May 2017 - Deborah Wilkes
Our review of mergers and acquisitions activity is essential reading for anyone with an interest in business development in the OTC/consumer healthcare industry.
The OTC Deal Trends 2017 Briefing from OTCToolbox provides a comprehensive guide to deals and trends in the global industry. It allows you to read less but know more.
This authoritative publication provides in-depth analysis and insights into past, present and future mergers and acquisitions activity. Download today to read about:
- 10 key OTC deal trends
- Purchase prices for OTC deals
- What might happen next?
- Creative approaches to mergers and acquisitions
- Trends in Brazil, China, India and Russia
- Trends in the vitamins, minerals and supplements (VMS) category
- Trends in the eyecare category
- Company profiles of six active acquirers in 2016 and early 2017, including Sanofi, RB, Johnson & Johnson, Prestige Brands and Mylan
OTC Deal Trends 2017 finds that consolidation continues at a brisk pace in the OTC/consumer healthcare industry, and mega deals still dominate the news. However, some acquirers are grappling with challenges as well as realising opportunities.
Other significant trends include generics companies building an OTC presence, private-equity firms buying and selling assets, and a high level of deal activity in the VMS category and emerging markets.
The Briefing, which has more than 130 pages, is written by OTC industry expert Deborah Wilkes, who is the Editor & Publisher of OTCToolbox. It is based on data from the OTCToolbox Deals Database, which contains details of more than 700 deals in the global OTC/consumer healthcare industry.
It is available to purchase and download immediately from the OTCToolbox website as a PDF. Make sure your team is well informed through a Multiple User Licence or a Global Licence for the Briefing. The Briefing is available free to people who have a current paid-for Annual Subscription to the OTCToolbox website.